Application of molecular markers in the diagnostics of thyroid focal lesions – current state of knowledge
Journal Title: OncoReview - Year 2012, Vol 2, Issue 2
Abstract
Thyroid nodular disease is a common disorder and affects about 20% of adult polish population. Due to the fact that methods currently applied in routine assessment of these changes often do not provide accurate diagnosis, the research are ongoing to identify novel markers of malignancy, including molecular ones. Thus far not a single marker was found, which characterises with satisfying sensitivity and specificity in the preoperative differentiation of benign and malignant thyroid lesions. None of the developed potential markers was included to the routine diagnostic procedures or guidelines, either. However, intensive research aiming to search for novel molecular markers, optimization of methods of detection and evaluation of their true clinical utility bring more and more promising results. Analysis of not a single studied marker cannot serve as independent diagnostic method. However, examination of a group of several markers, together with ultrasound examination and classic cytological examination, may contribute to the increase in sensitivity and specificity in detection of malignant lesions and thus, make further therapeutic decisions in a patient with thyroid nodular disease easier.
Authors and Affiliations
Marek Ruchała, Kosma Woliński, Maciej Fularz, Ewelina Szczepanek-Parulska
Keywords
Related Articles
- EP ID EP53150
- DOI -
- Views 215
- Downloads 0
Coronary angioplasty and aortic valve replecement in two patients with multiple myeloma - case reports
Multiple myeloma is a hematological disorder characterized by a clonal proliferation of atypical plasma cells, which produce a monoclonal immunoglobulin. The annual incidence rate in Europe is about 4.5/100 000 persons,...
Późny nawrót przewlekłej białaczki szpikowej po alogenicznym przeszczepieniu komórek macierzystych - opis przypadku
Przewlekła białaczka szpikowa obecnie w większości przypadków jest chorobą dobrze poddającą leczeniu inhibitorami kinazy tyrozynowej. Nadal jednak jedyną procedurą leczniczą dającą możliwość wyleczenia jest aloprzeszczep...
Interstitial pneumonia during treatment with rituximab
Rituximab (RTX) is a chimeric anti-CD20 antibody. It plays an important role in the treatment of B cell lymphomas and diseases of autoaggression. RTX-induced lung disease is a rare entity, which should be considered in t...
Mitral regurgitation after anthracycline exposure: a case report
We report the case of a 66-year-old African American female with a history of breast cancer previously treated with anthracycline based chemotherapy presenting with significant mitral regurgitation. She initially had pre...
Leczenie okołooperacyjne gruczolakoraka przełyku, połączenia przełykowo-żołądkowego oraz żołądka; nowe standardy postępowania i kontrowersje
Rak przełyku, połączenia przełykowo-żołądkowego oraz żołądka to duży problem diagnostyczny i terapeutyczny. Nawet po zabiegach chirurgicznych (R0) odsetek przeżyć 5-letnich jest niezadowalający. Chemioterapia okołooperac...